Lipid Intermediates

DSM is the global leader in the production of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) derived from either sustainable marine sources or microbial fermentation. We have a strong legacy of trust in the development and production of high-quality lipid products and we continue to innovate in the development and commercialization of new molecules, including arachadonic acid (ARA), docosapentaenoic acid (DPA), and others. 

The Omega-3 fatty acids EPA and DHA have important roles in human health. Experts agree that EPA and DHA are a safe and effective option for reducing plasma triglycerides, and that EPA in particular is important for cardiovascular disease risk management.

In addition to their recognized roles in cardiovascular disease risk management, omega-3 fatty acids are under investigation as potential therapeutic candidates for a variety of health conditions, ranging from stroke, traumatic brain injury, even as a treatment for chemotherapy-related complications.

We are not just limited to EPA and DHA. DSM has the unique capability to produce a variety of lipid products from marine oils and algal fermentation to meet your custom specification. We want to work with you to get your product into the hands of patients around the world.

Contact us to find out more about how we can help you bring your lipid-based APIs to the market.